Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 3Phase 3 3Phase NA 1

Status

Completed 11Unknown 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Vomiting 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Aprepitant × Clear all
NCT05711823 2024-01-23

Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC

Guangxi Medical University

Phase 3 Unknown
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02979548 2017-01-25

Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy

All India Institute of Medical Sciences

Phase 3 Unknown
116 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00571168 2010-01-12

EmNa

Heidelberg University

Phase 3 Unknown
362 enrolled
Plasma cell

Multiple Myeloma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡